Business Context and Reporting Period
Company: E. I. du Pont de Nemours and Company (DuPont)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 30, 1996
Business Overview: DuPont operates across Chemicals, Fibers, Polymers, Petroleum, and Diversified Businesses segments. The company reported record quarterly net income for the second quarter of 1996.
Key Financial Metrics
| Metric (Dollars in Millions) | Q2 1996 | Q2 1995 | YTD 1996 | YTD 1995 |
|---|---|---|---|---|
| Sales | $11,148 | $11,076 | $21,917 | $21,578 |
| Net Income | $1,001 | $938 | $1,880 | $1,897 |
| Earnings Per Share (EPS) | $1.78 | $1.70 | $3.35 | $3.07 |
| Cash Provided by Operations (YTD) | $2,356 | $2,328 | ||
| Capital Expenditures (YTD) | ||||
| Debt Ratio (Total Debt/Capitalization) | 51% | 58% (Dec 31, 1995) | ||
| Current Ratio | 1.0:1 | 0.9:1 (Dec 31, 1995) |
Material Changes vs. Prior Period
- Profitability: Q2 1996 net income reached $1 billion, the first time quarterly net income exceeded this threshold. EPS increased 5% on a nonrecurring-adjusted basis compared to Q2 1995.
- Sales Volume vs. Price: Chemicals and Specialties sales volumes increased 4%, but lower selling prices (driven by a stronger U.S. dollar) offset these gains, resulting in flat earnings for the segment. Petroleum segment earnings rose 15% due to higher oil and gas prices.
- Share Count: Average shares outstanding decreased 9% year-over-year due to the 1995 stock redemption from Seagram, contributing to higher EPS despite flat YTD net income.
- Asset Sales: Proceeds from asset sales surged to $1.2 billion in the first half of 1996 (vs. $185 million in 1995), including sales of medical products and interests in the DuPont Dow Elastomers joint venture.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Capital Expenditures: Management expects full-year 1996 capital expenditures to be approximately $3.8 billion.
- Debt Reduction: The company aims to reduce its debt ratio to approximately 45% by year-end 1996 using internally generated funds and an additional $500 million in asset sale proceeds.
- Recent Transaction: On July 24, 1996, DuPont repurchased warrants from Seagram for $500 million, funded by commercial paper. This transaction was followed by the retirement of 156 million treasury shares.
Risks and Contingencies
- Benlate Litigation: Over 700 lawsuits remain regarding alleged crop damage from "Benlate" 50 DF fungicide. DuPont maintains the product did not cause damage. A $3.98 million jury verdict is currently on appeal.
- Polybutylene Plumbing: DuPont is a defendant in class actions regarding polybutylene plumbing leaks. The company has agreed to contribute up to $120 million toward repair costs.
- Environmental: Ongoing audits and settlements with the EPA and state agencies regarding release reporting and hazardous waste handling. Penalties are generally capped or being negotiated.
Investor Verification Checklist
- Warrant Repurchase Impact: Verify the accounting treatment and cash flow impact of the $500 million Seagram warrant repurchase and subsequent treasury stock retirement.
- Benlate Liability Exposure: Monitor the status of the pending appeals and the potential for additional accruals beyond current estimates.
- Debt Ratio Trajectory: Confirm progress toward the 45% debt ratio target given the reliance on future asset sales.
- Petroleum Price Sensitivity: Assess the sustainability of the 15% earnings increase in the Petroleum segment given its reliance on volatile oil and gas prices.
- Nonrecurring Items: Review the specific components of the $34 million nonrecurring charge in Q2 1996 to understand the baseline operating performance.